TIB MOLBIOL
TIB MOLBIOL has been providing custom synthesis of oligonucleotides to a growing number of customers worldwide. Our products are used in the fields of life science research, medical diagnostics, product quality assessment and environmental analysis. Being one of the first suppliers of synthetic DNA in Europe, we have not only set standards of quality and service, but continue to lead in fulfilling your demanding requirements for high quality products and services. The potential of Real-Time PCR... was recognized by TIB Molbiol immediately upon its introduction in 1997. The company focused on this new technology by researching new application approaches and experimenting with different technical formats. In 1998 Boehringer Mannheim (now Roche) introduced the LightCycler® Real-Time PCR Instrument. Based on the novel detection format of HybProbes and an innovative thermal cycling technology, the instrument revolutionized Real-Time PCR not only by speeding up the process but also by the versatility of possible experimental applications. TIB Molbiol embraced the new chemistry of HybProbes and embarked with Boehringer Mannheim in a mutual effort to increase the application scope and attractiveness of the instrument.
TIB MOLBIOL
Industry:
Biotechnology Life Science Manufacturing
Founded:
1990-01-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.tib-molbiol.com
Status:
Active
Contact:
+49 30 78 79 94 55
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache COVID-19 Apple Mobile Web App Capable Apache 2.4 Lorem Ipsum Debian Google No Translate SEO_H2
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Merck
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Employees Featured
Founder
Official Site Inspections
http://www.tib-molbiol.com
- Host name: tib-molbiol.bbtt.net
- IP address: 87.225.129.108
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Tib Molbiol" on Search Engine
TIB MOLBIOL - Research for Life - TIB MOLBIOL
TIB Molbiol offers custom synthesis of oligonucleotides utilized in life science research, medical diagnostics, product quality assessment and environmental analysis applications.See details»
Tib Molbiol - Crunchbase Company Profile & Funding
TIB MOLBIOL has been providing custom synthesis of oligonucleotides to a growing number of customers worldwide. Our products are used in the fields of life science research, medical diagnostics, product quality assessment and environmental analysis. Being one of the first suppliers of synthetic DNA in Europe, we have not only set standards ofSee details»
Roche completes purchase agreement with long-term partner
Basel, 1 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has completed its share purchase agreement to acquire 100 percent of the outstanding shares of TIB Molbiol Group....See details»
Roche signs definitive share purchase agreement with
Basel, 09 September 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has signed a definitive share purchase agreement to acquire 100% of the outstanding shares of the TIB Molbiol ...See details»
Roche signs definitive share purchase agreement with long-term …
September 8, 2021 · 5 min read. Roche to acquire the TIB Molbiol Group with the expectation to close in fourth quarter of 2021. TIB Molbiol excels in ultra-rapid assay development for...See details»
Roche completes acquisition of TIB Molbiol Group
Dec 1, 2021 Roche has completed its acquisition of TIB Molbiol Group, which will continue to operate as a subsidiary within Roche’s diagnostics division. Roche and TIB Molbiol will build on their capabilities for the rapid development of assays for emerging pathogens and potential health threats, such as infectious diseases, Roche said.See details»
Roche Acquires TIB Molbiol to Boost Molecular Diagnostics Profile
September 15, 2021 - Roche recently signed a definitive share purchase agreement to acquire 100 percent of the outstanding shares of TIB Molbiol Group to enhance its molecular diagnostic solutions portfolio.See details»
Roche Bolsters Diagnostics Division with Acquisition of TIB Molbiol ...
Germany-based TIB Molbiol Group develops ultra-rapid assays aimed at infectious diseases. The acquisition will enable Roche to expand its own diagnostic portfolio. TIB’s diagnostics portfolio includes more than 45 CE-IVD assays and more than 100 research use assays that are already available for use through Roche`s LightCycler PCR instruments …See details»
Roche ties the knot with longtime testmaking partner TIB Molbiol after ...
By Conor Hale Sep 9, 2021 12:20pm. COVID-19 diagnostic tests infectious disease mergers and acquisitions. Roche has snapped up its longtime test-making partner, TIB Molbiol, to help boost its...See details»
Roche to boost molecular diagnostics range with TIB Molbiol …
Sep 9, 2021 June 5, 2023. Share this article. Roche has worked with TIB Molbiol for more then 20 years to quickly address biological threats. Credit: Roche. Roche has signed a definitive agreement to acquire all the outstanding shares of biotech company TIB Molbiol Group in a bid to bolster its molecular diagnostics portfolio.See details»
Company - TIB MOLBIOL
Research for Life. Company. TIB Molbiol is a medium-sized biotech company who has supplied the global market for over 30 years with reagents for research and medical diagnostics. We are known for our innovation, product quality, design and time to market.See details»
Roche to acquire TIB Molbiol to expand PCR-testing portfolio
Sep 13, 2021 Swiss healthcare company Roche has signed a definitive agreement to acquire 100% outstanding shares of TIB Molbiol Group for an undisclosed amount. The acquisition builds on more than 20 years of collaboration between the two companies, focused on several viral infections, along with recent SARS-CoV-2 and its variants.See details»
Roche to acquire TIB Molbiol Group - 2021 - Wiley Analytical …
Sep 14, 2021 TIB Molbiol’s comprehensive portfolio of over 45 CE-IVD assays and more than 100 research use assays are already today available on Roche’s large installed base of LightCycler PCR systems and MagNA Pure sample preparation systems.See details»
Roche completes purchase agreement with long-term partner TIB Molbiol ...
Basel, 1 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has completed its share purchase agreement to acquire 100 percent of the outstanding shares of TIB Molbiol Group....See details»
Portrait: TIB Molbiol - Test kits from Berlin detect coronaviruses ...
In addition to the 40,000 square metre facility in Berlin, TIB Molbiol has offices and production facilities in the USA, Italy, Spain, Colombia and Australia. There, around 50 employees develop, produce and sell diagnostic and research reagents.See details»
Roche acquires Tib Molbiol - 2021-09-09 - Crunchbase
Overview. Acquired Organization: Tib Molbiol TIB MOLBIOL has been providing custom synthesis of oligonucleotides to a growing number of customers worldwide. Acquiring Organization: Roche Roche is a pharmaceutical and diagnostics company that focuses on improving people’s lives. Announced Date Sep 9, 2021. Acquisition Type Acquisition.See details»
Press Release : Roche signs definitive share purchase …
Basel, 09 September 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has signed a definitive share purchase agreement to acquire 100% of the outstanding shares of the TIB Molbiol Group. Closing of the transaction is subject to customary conditions and is expected in the fourth quarter of 2021.See details»
Roche completes acquisition of TIB Molbiol - Medical Dialogues
Dec 3, 2021 Roche completes... Roche completes acquisition of TIB Molbiol. Written by Ruchika Sharma Published On 2021-12-03T16:24:42+05:30 | Updated On 3 Dec 2021 10:54 AM GMT. Basel: Roche has recently announced the company has completed its share purchase agreement to acquire 100 percent of the outstanding shares of TIB Molbiol Group.See details»
Roche develops unique PCR tests to detect the monkeypox
May 25, 2022 Roche and its subsidiary TIB Molbiol have developed three different LightMix® Modular Virus kits for the detection of the monkeypox virus. Multiple clusters of monkeypox virus have been...See details»
Roche Holding AG completed the acquisition of TIB Molbiol …
December 30, 2021. Roche Holding AG (SWX:ROG) agreed to acquire Tib Molbiol on September 9, 2021. Closing of the transaction is subject to customary conditions and is expected in the fourth quarter of 2021. With over 45 CE-IVD assays and more than a 100 research-use-only assays joining the Roche family.See details»